drugset / Trial / NCT04802928

Healing of Ischemic Leg Ulcers in Patients Treated With iSONIAzid

NCT04802928

Phase 2 Withdrawn Pharma 2100
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The main objective of this trial is to study the healing effect of an oral drug (isoniazid) in patients with ischemic (arterial) leg ulcers defined by a systolic toe pressure \<40 mm Hg.

Timeline

Start
2008-04
Primary completion
2008-09
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Isoniazid Small molecule 150 mg Oral

Indications